Blood Pressure Medicines
Also known as: Antihypertensive medicines, High blood pressure medicines
Methodology & AI Transparency ⓘ
Blood Pressure Medicines Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is high blood pressure? High blood pressure , also called hypertension, is when blood puts too much pressure against the walls of your arteries.
- 2 Real-world patient consensus: Mapped to High Blood Pressure & Vascular Health under ICD-10-CM I82.9 for Blood Pressure Medicines clinical workups.
- 3 Typical cash cost range: Workup highlights for Blood Pressure Medicines (I82.9): D-dimer risk exclusion [Blood Pressure Medicines I82.9].
- 4 Top reported side effects / signs: Longitudinal Blood Pressure Medicines monitoring tracks Serum Creatinine & in Blood Pressure Medicines (I82.9: Potassium) toward K+ 4.0 – 4.8 mEq/L (I82.9).
Ask our AI Specialists anything about Blood Pressure Medicines
What Is Blood Pressure Medicines?
What is high blood pressure? High blood pressure , also called hypertension, is when blood puts too much pressure against the walls of your arteries. Almost half of American adults have high blood pressure, usually with no symptoms. But it can cause serious problems such as stroke , heart failure , heart attack , and kidney disease .
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Blood Pressure Medicines (I82.9) center on renin-angiotensin-aldosterone system upregulation [Blood Pressure Medicines I82.9]. Cross-referenced with NIH MeSH (Antihypertensive Agents), targeted blood pressure interventions aim to normalize Serum Creatinine & in Blood Pressure Medicines (I82.9: Potassium).
Common Symptoms & Clinical Signs
- • Being physically active
- • Reducing sodium in your diet
- • Presentation of Blood Pressure Medicines (I82.9): morning occipital headache, in Blood Pressure Medicines (I82.9: pulsatile tinnitus, or)
- • Secondary Blood Pressure Medicines clinical sign: calf cramping or in Blood Pressure Medicines (I82.9: claudication triggered by)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Blood Pressure Medicines Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I82.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Creatinine & in Blood Pressure Medicines (I82.9: Potassium) | K+ 4.0 – 4.8 mEq/L (I82.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Blood Pressure Medicines I82.9] | < 15 mg/g (I82.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Blood Pressure Medicines (I82.9: Pressure) | < 120/75 mmHg (I82.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Blood Pressure Medicines
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Brukinsa (Zanubrutinib) Brukinsa • RxCUI RXN-B72579122 | Kinase Inhibitor | 83% | $0.9900 | $ 79.78 /mo |
| Avapritinib Ayvakit • RxCUI RXN-72064110-2593 | Kinase Inhibitor | 88% | $3.3100 | $ 142.56 /mo |
| Sudafed Sinus 12 Hour Pressure Plus Pain (Naproxen Sodium and Pseudoephedrine Hydrochloride) Sudafed Sinus 12 Hour Pressure Plus Pain • RxCUI 1367426 | Nonsteroidal Anti-inflammatory Drug | 80% | $0.1442 | $ 18.88 /mo |
| Timolol Betimol, Timoptic • RxCUI 208560 | beta-Adrenergic Blocker | 74% | $31.0625 | $ 6.97 /mo |
| Latanoprost Ophthalmic Solution 0.005% Iyuzeh • RxCUI 314072 | Prostaglandin Analog | 75% | $10.1187 | $ 185.00 /mo |
| Zanubrutinib Brukinsa • RxCUI RXN-72579122-2253 | Kinase Inhibitor | 80% | $3.2000 | $ 138.10 /mo |
| Latanoprostene Bunod Vyzulta • RxCUI 1988394 | FDA Prescription Therapeutic Agent | 78% | $99.2842 | $ 185.00 /mo |
| Brinzolamide Azopt • RxCUI 213272 | Carbonic Anhydrase Inhibitor | 93% | $35.0627 | $ 62.50 /mo |
| Tevimbra (Tislelizumab-Jsgr) Tevimbra • RxCUI RXN-B72579121 | Programmed Death Receptor-1 Blocking Antibody | 84% | $3.0600 | $ 228.82 /mo |
| Travoprost Travatan Z • RxCUI 284008 | Prostaglandin Analog | 93% | $94.1791 | $ 15.22 /mo |
| Brimonidine Tartrate Alphagan P, Lumify Preservative Free Eye Drops • RxCUI 861204 | alpha-Adrenergic Agonist | 92% | $8.1556 | $ 9.60 /mo |
| Mylanta Gas Minis Assorted Fruit Flavor (Simethicone) Mylanta Gas Minis Assorted Fruit Flavor • RxCUI 314221 | Skin Barrier Activity | 83% | $0.0473 | $ 11.90 /mo |
| Norepinephrine Bitartrate Levophed • RxCUI 242969 | Catecholamine | 76% | $2.1200 | $ 94.36 /mo |
| Brimonidine Tartrate and Timolol Maleate Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, Brimonidine Tartrate/Timolol Maleate • RxCUI 861635 | alpha-Adrenergic Agonist | 92% | $1.8390 | $ 82.98 /mo |
| Timolol Maleate Timoptic, Timolol Gfs • RxCUI 1923428 | beta-Adrenergic Blocker | 82% | $1.0344 | $ 6.97 /mo |
| Dorzolamide Hydrochloride Timolol Maleate Cosopt • RxCUI 1923432 | Carbonic Anhydrase Inhibitor | 93% | $0.8853 | $ 10.75 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Blood Pressure Medicines)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Achieved blood pressure and heart and blood vessel outcomes in high-risk: What a 8,407-Participant Study Found Mean achieved SBP less than 120 mm Hg during treatment was associated with increased risk of heart and blood vessel outcomes except for heart attack and stroke. Lancet (London, England) • 2017-06-03 • Meta-Analysis | N = 8,407 | 99/100 | PMID 28390695 ↗ |
| New Insights on Telmisartan and amlodipine single-pill combinations vs amlodipine single-drug: What a 1,097-Participant Study Found Superior BP reductions were also seen with T40-T80/A5 vs A10, with BP goal rates at least as high as with A10; however, there was significantly more peripheral edema with A10 (27.2% vs 4.3% for pooled. Journal of clinical hypertension (Greenwich, Conn.) • 2011-07-15 • Randomized Controlled Trial | N = 1,097 | 96/100 | PMID 21762357 ↗ |
| Check Your Medicine Cabinet: Early Alert: B. Braun Removes Streamline Bloodline Set for Dialog+ The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss. FDA MedWatch Safety Alerts • 2026-10-27 • FDA Safety Alert | Multi-cohort | 95/100 | PMID FDA_MEDWATCH-112457955 ↗ |
| Randomized trials of telmisartan vs. Losartan: Which Works Better for Reduction of ambulatory blood pressure? Pooled analysis suggested significant reductions in all of 24-h (MD of systolic/diastolic BP, -2.09/-1.57 mm Hg; 95% CI, -3.39/-2.32 to -0.79/-0.82 mm Hg), last 6-h (-2.96/-2.15 mm Hg; -3.80/-2.72 to -2.13/-1.59 mm Hg),... Hypertension research : official journal of the Japanese Society of Hypertension • 2013-11-15 • Meta-Analysis | N = 2,409 | 94/100 | PMID 23945962 ↗ |
| Randomized trials of telmisartan vs. Valsartan therapy: Which Works Better for Blood pressure reduction? When data from the single-drug treatment and combination therapy (with hydrochlorothiazide) trials were pooled separately, telmisartan therapy was associated with a statistically significant difference in BP reductions... Hypertension research : official journal of the Japanese Society of Hypertension • 2013-07-15 • Meta-Analysis | N = 5,422 | 94/100 | PMID 23344134 ↗ |
Blood Pressure Medicines Patient Community & “People Like Me” Threads
Filter Blood Pressure Medicines community threads and patient logs by age, biological sex, dosage, and treatment duration.